SP-2-225

N/A

Report date: 2023/04/12 16:12:23
NME

Base Information

Drug NameSP-2-225
Drug Alias NameSP-2-225
ClassificationSmall molecules
Mechanisms of ActionHistone deacetylase 6 inhibitors
TargetsHistone deacetylase 6
Therapy Area/IndicationsLung NeoplasmsBreast NeoplasmsMultiple Myeloma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShuttle Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesShuttle Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsBreast NeoplasmsMultiple Myeloma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A